Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (7)

2014

  1. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

2009

  1. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-Week analysis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 2, pp. 147-152

  2. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201

2008

  1. Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 6, pp. 1359-1361

  2. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV

    AIDS, Vol. 22, Núm. 2

2005

  1. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-Week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK study)

    Journal of Acquired Immune Deficiency Syndromes, Vol. 40, Núm. 3, pp. 280-287

2004

  1. Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load

    Clinical Infectious Diseases, Vol. 39, Núm. 7, pp. 1024-1029